6505--Lamotrigine Immediate Release (IR) Tablets
Closed Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- 36E79725R0004
- Agency
- National Acquisition Center Headquarters, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
-
- Ray Roldan raymond.roldan@va.gov (708) 786-4930
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs (VA) National Acquisition Center is issuing a solicitation (Solicitation Number 36E79725R0004) to establish a supply source for Lamotrigine Immediate Release (IR) Tablets. The purpose is to enable the VA, Department of Defense (DoD), Indian Health Service (IHS), and Bureau of Prisons (BOP) to purchase the specified Lamotrigine tablet strengths and package sizes through the VA and DoD Pharmaceutical Prime Vendor (PPV) programs. The contract will have a one-year base period and four one-year option periods. Offerors must submit pricing for all line items for the base year and each option year. The Government will evaluate offers in accordance with FAR Parts 12, 15, and 25. Offerors will be required to maintain an agreement with the VA and DoD PPV contractors throughout the contract period.
This solicitation is not set aside for any specific business size or type. There are no details provided about any incumbent contractors. The Government estimates annual requirements for the products, but there is no guarantee of the exact quantities to be purchased. Pricing must include a 0.5% Cost Recovery Fee. The solicitation also includes requirements related to drug supply chain security, recalls, and manufacturing facilities. The original due date of November 21, 2024 has been extended to December 3, 2024 at 2:30 PM CT.
Notice text
2 versions
Update #2 · Latest ·
Amendment for Lamotrigine IR Tablets
Update #1 ·
N/A
Attachments
| File | Type | Posted |
|---|---|---|
| 36E79725R0004 0001.docx | DOCX document | |
| 36E79725R0004.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6505--Lamotrigine Tablets Jubilant Cadista Pharmaceuticals, Inc. Base Ordering Period 6/16/2025 - 6/15/2026 | Award Notice | |
| 6505--Lamotrigine Immediate Release (IR) Tablets | Solicitation | |
| 6505--Lamotrigine Immediate Release (IR) Tablets | Pre-Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity